These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25341120)

  • 21. V gamma 9V delta 2 T cell response to colon carcinoma cells.
    Corvaisier M; Moreau-Aubry A; Diez E; Bennouna J; Mosnier JF; Scotet E; Bonneville M; Jotereau F
    J Immunol; 2005 Oct; 175(8):5481-8. PubMed ID: 16210656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harnessing γδ T cells in anticancer immunotherapy.
    Hannani D; Ma Y; Yamazaki T; Déchanet-Merville J; Kroemer G; Zitvogel L
    Trends Immunol; 2012 May; 33(5):199-206. PubMed ID: 22364810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cutaneous malignancy by gammadelta T cells.
    Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC
    Science; 2001 Oct; 294(5542):605-9. PubMed ID: 11567106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
    Miyashita M; Shimizu T; Ashihara E; Ukimura O
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
    Braza MS; Klein B
    Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells.
    Shojaei H; Oberg HH; Juricke M; Marischen L; Kunz M; Mundhenke C; Gieseler F; Kabelitz D; Wesch D
    Cancer Res; 2009 Nov; 69(22):8710-7. PubMed ID: 19887600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells
    Wang Z; Wang Z; Li S; Li B; Sun L; Li H; Lin P; Wang S; Teng W; Zhou X; Ye Z
    Front Immunol; 2018; 9():1239. PubMed ID: 29910819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium valproate sensitizes non-small lung cancer A549 cells to γδ T-cell-mediated killing through upregulating the expression of MICA.
    Du XZ; Li QY; Du FW; He ZG; Wang J
    J Biochem Mol Toxicol; 2013 Nov; 27(11):492-8. PubMed ID: 23918508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of phloretin on human γδ T cells killing colon cancer SW-1116 cells.
    Zhu SP; Liu G; Wu XT; Chen FX; Liu JQ; Zhou ZH; Zhang JF; Fei SJ
    Int Immunopharmacol; 2013 Jan; 15(1):6-14. PubMed ID: 23174508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling.
    Martinet L; Jean C; Dietrich G; Fournié JJ; Poupot R
    Biochem Pharmacol; 2010 Sep; 80(6):838-45. PubMed ID: 20470757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct pattern of human Vdelta1 gammadelta T cells recognizing MICA.
    Li J; Cui L; He W
    Cell Mol Immunol; 2005 Aug; 2(4):253-8. PubMed ID: 16274622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
    Guo BL; Liu Z; Aldrich WA; Lopez RD
    Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Determinants of Target Cell Recognition by Human γδ T Cells.
    Simões AE; Di Lorenzo B; Silva-Santos B
    Front Immunol; 2018; 9():929. PubMed ID: 29755480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
    Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
    Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells.
    Bhat J; Dubin S; Dananberg A; Quabius ES; Fritsch J; Dowds CM; Saxena A; Chitadze G; Lettau M; Kabelitz D
    Front Immunol; 2019; 10():569. PubMed ID: 30972064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
    Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
    Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?
    Thedrez A; Sabourin C; Gertner J; Devilder MC; Allain-Maillet S; Fournié JJ; Scotet E; Bonneville M
    Immunol Rev; 2007 Feb; 215():123-35. PubMed ID: 17291284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.